{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:18Z","timestamp":1792179558545,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,2,13]]},"DOI":"10.1007\/s40257-018-0387-0","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T13:46:45Z","timestamp":1536673605000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study"],"prefix":"10.1007","volume":"20","clinical-trial-number":[{"clinical-trial-number":"tctr20160912002","registry":"10.18810\/tctr"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0563","authenticated-orcid":false,"given":"Poonkiat","family":"Suchonwanit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0185-9752","authenticated-orcid":false,"given":"Wimolsiri","family":"Iamsumang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-4355","authenticated-orcid":false,"given":"Salinee","family":"Rojhirunsakool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"issue":"3 Suppl","key":"387_CR1","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","volume":"45","author":"EA Olsen","year":"2001","unstructured":"Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45(3 Suppl):S70\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"387_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","volume":"144","author":"MP Birch","year":"2001","unstructured":"Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144(2):297\u2013304.","journal-title":"Br J Dermatol"},{"key":"387_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/CCID.S153768","volume":"11","author":"S Rojhirunsakool","year":"2017","unstructured":"Rojhirunsakool S, Suchonwanit P. Parietal scalp is another affected area in female pattern hair loss: an analysis of hair density and hair diameter. Clin Cosmet Investig Dermatol. 2017;11:7\u201312.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"387_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jamadermatol.2016.5790","volume":"153","author":"EJ van Zuuren","year":"2017","unstructured":"van Zuuren EJ, Fedorowicz Z. Interventions for female pattern hair loss. JAMA Dermatol. 2017;153(3):329\u201330.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"387_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaad.2008.07.001","volume":"59","author":"NE Rogers","year":"2008","unstructured":"Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008;59(4):547\u201366.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"387_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","volume":"77","author":"A Adil","year":"2017","unstructured":"Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136\u201341.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"387_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","volume":"25","author":"JH Yeon","year":"2011","unstructured":"Yeon JH, Jung JY, Choi JW, Kim BJ, Youn SW, Park KC, Huh CH. 5\u00a0mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. J Eur Acad Dermatol Venereol. 2011;25(2):211\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"387_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/archderm.142.3.298","volume":"142","author":"M Iorizzo","year":"2006","unstructured":"Iorizzo M, Vincenzi C, Voudouris S, et al. Finasteride treatment of female pattern hair loss. Arch Dermatol. 2006;142(3):298\u2013302.","journal-title":"Arch Dermatol"},{"issue":"1","key":"387_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0974-7753.114709","volume":"5","author":"R Oliveira-Soares","year":"2013","unstructured":"Oliveira-Soares R, E Silva JM, Correia MP, Andr\u00e9 MC. Finasteride 5\u00a0mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women. Int J Trichol. 2013;5(1):22\u20135.","journal-title":"Int J Trichol"},{"issue":"6","key":"387_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4103\/0378-6323.144162","volume":"80","author":"IH Boersma","year":"2014","unstructured":"Boersma IH, Oranje AP, Grimalt R, et al. The effectiveness of finasteride and dutasteride used for 3\u00a0years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2014;80(6):521\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5 Pt 1","key":"387_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1067\/mjd.2000.107953","volume":"43","author":"VH Price","year":"2000","unstructured":"Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5 Pt 1):768\u201376.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"387_CR12","first-page":"457","volume":"17","author":"SW Lee","year":"2018","unstructured":"Lee SW, Juhasz M, Mobasher P, et al. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol. 2018;17(4):457\u201363.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"387_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/09546639709160517","volume":"8","author":"F Mazzarella","year":"1997","unstructured":"Mazzarella F, Loconsole F, Cammisa A, et al. Topical finasteride in the treatment of androgenetic alopecia: preliminary evaluations after a 16-month therapy course. J Dermatol Treat. 1997;8(3):189\u201392.","journal-title":"J Dermatol Treat"},{"issue":"10","key":"387_CR14","first-page":"1312","volume":"95","author":"C Tanglertsampan","year":"2012","unstructured":"Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil\/0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012;95(10):1312\u20136.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"387_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/2229-5178.148925","volume":"6","author":"BS Chandrashekar","year":"2015","unstructured":"Chandrashekar BS, Nandhini T, Vasanth V, et al. Topical minoxidil fortified with finasteride: an account of maintenance of hair density after replacing oral finasteride. Indian Dermatol Online J. 2015;6(1):17\u201320.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"387_CR16","first-page":"253","volume":"6","author":"S Sheikh","year":"2015","unstructured":"Sheikh S, Ahmad A, Ali SM, et al. A new topical formulation of minoxidil and finasteride improves hair growth in men with androgenetic alopecia. J Clin Exp Dermatol Res. 2015;6(1):253.","journal-title":"J Clin Exp Dermatol Res"},{"issue":"10","key":"387_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.5414\/CP202119","volume":"52","author":"M Caserini","year":"2014","unstructured":"Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther. 2014;52(10):842\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"387_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15171","author":"P Suchonwanit","year":"2018","unstructured":"Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil versus 3% minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018. https:\/\/doi.org\/10.1111\/jdv.15171.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3 Suppl","key":"387_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2133.2011.10630.x","volume":"165","author":"R Sinclair","year":"2011","unstructured":"Sinclair R, Patel M, Dawson TL Jr, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol. 2011;165(3 Suppl):12\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"387_CR20","first-page":"414","volume":"15","author":"LR Seale","year":"2016","unstructured":"Seale LR, Eglini AN, McMichael AJ. Side effects related to 5 alpha-reductase inhibitor treatment of hair loss in women: a review. J Drugs Dermatol. 2016;15(4):414\u20139.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"387_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/exd.12945","volume":"25","author":"DH Rushton","year":"2016","unstructured":"Rushton DH, Norris MJ, Van Neste D. Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair. Exp Dermatol. 2016;25(6):482\u20134.","journal-title":"Exp Dermatol"},{"issue":"14","key":"387_CR22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","volume":"76","author":"Y Kelly","year":"2016","unstructured":"Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76(14):1349\u201364.","journal-title":"Drugs"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-018-0387-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:37:29Z","timestamp":1628617049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-018-0387-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,13]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0387-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"11 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"clinicaltrials.in.th; identifier TCTR20160912002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"PS, WI, and SR have no conflicts of interest that are directly relevant to the content of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and in compliance with the International Conference on Harmonization\u2014Good Clinical Practice and local regulatory requirements. The study was reviewed and approved by the appropriate independent ethics committees, and written informed consent was obtained from all subjects prior to study initiation. This study was approved by the MU-IRB (Mahidol University Institutional Review Board) on 16 September 2015 (Protocol number 09-58-20).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}